Taken together, morphological analysis and gene expression, proteomic and functional data all support the conclusion that mitochondrial dysfunction is present early, before the detectible stages of AD pathology, including the accumulation of Aβ plaques or tau tangles, and contributes to AD pathogenesis. The gene discussed is MAPT; the disease is Alzheimer disease.